GlassScriptPhysician profile
Uday Mehta
NPI 1437380359
$4,842.81
in general payments reported to CMS, 2019-2025
11 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $432 · 2021: $1,783 · 2022: $1,612 · 2023: $62.91 · 2024: $360 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salvin Dental Specialties, INC. | $1,727.52 | 2021 | |
| Geistlich Pharma, North America, INC. | $1,212.92 | 2022 | |
| Biohorizons Implant Systems INC. | $907.08 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| Straumann USA LLC | $478.14 | 2021-2025 | |
| Stryker Corporation | $238.99 | 2019-2024 | Na, Medpor Titan |
| Orapharma, A Division of Bausch Health US, LLC | $93.51 | 2021-2025 | Ossix Plus, Arestin |
| Zimmer Biomet Holdings, INC. | $73.83 | 2020 | |
| Depuy Synthes Sales INC. | $56.59 | 2022 | |
| Zimvie INC. | $25.20 | 2022 | |
| Kls-Martin L.P. | $15.94 | 2021 | |
| Carestream Dental, LLC | $13.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uday Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.